ロード中...
CPA4 Promotes EMT in Pancreatic Cancer via Stimulating PI3K-AKT-mTOR Signaling
BACKGROUND: Carboxypeptidase A4 (CPA4), as a novel tumor biomarker, is prevalently observed in various cancers. However, the potential role of CPA4 in pancreatic cancer (PC), to our knowledge, has not been fully clarified. MATERIALS AND METHODS: We systematically explored the detailed function of CP...
保存先:
| 出版年: | Onco Targets Ther |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7457871/ https://ncbi.nlm.nih.gov/pubmed/32922037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S257057 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|